Observational study / 2013
In Crohn's disease and ulcerative colitis, low vitamin D was linked to higher risk of surgery and hospitalization, while normalization reduced surgery risk.
Using a multi-institution inflammatory bowel disease cohort of 3,217 patients, researchers evaluated the association between plasma 25(OH)D levels and subsequent risk of surgery or hospitalization. In Crohn's disease (CD), multivariable analysis showed 25(OH)D <20 ng/mL was linked to increased risk of surgery (OR 1.76; 95% CI, 1.24-2.51) and hospitalization (OR 2.07; 95% CI, 1.59-2.68) compared to levels ≥30 ng/mL, with similar estimates in ulcerative colitis. Furthermore, patients with CD who normalized their 25(OH)D levels from <30 ng/mL had a lower likelihood of surgery compared with those who remained deficient (OR 0.56; 95% CI, 0.32-0.98).
Shows an association, not proof of cause and effect.
- Study type
- Multi-institution retrospective cohort study
- Who was studied
- 3,217 patients with inflammatory bowel disease (55% Crohn's disease; mean age 49 years)
- What was measured
- Subsequent risk of inflammatory bowel disease-related surgery or hospitalization
THE PAPER
Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease.
Ananthakrishnan AN, Cagan A, Gainer VS, Cai T, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw SY, Churchill S, Karlson EW, Kohane I, Plenge RM, Murphy SN, Liao KP. Inflamm Bowel Dis, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.